Activity of pazopanib in chemoresistant patients with germ cell tumours (GCT): Early findings of the open-label, single-group, phase 2 pazotest-01 trial
Necchi A
ā€¢
Mariani L
ā€¢
Giannatempo P
altro
Gianni AM
2014
Periodico
EUROPEAN UROLOGY. SUPPLEMENTS
Archivio
Diritti
closed access
license:non pubblico
license uri:iris.2.pri01